Archives

Somersan-Karakaya

Characterize host and bacterial pathways that are important in Mycobacterium tuberculosis survival in the host and identify targets whose inhibition will render Mtb more susceptible to host defenses.

Nathan

Carl Nathan

The lab studies host-pathogen interactions, focusing on macrophages and Mycobacterium tuberculosis (Mtb). Most projects in the lab today fall into one or more of the following broad topics: host pathways controlling susceptibility and resistance ...
Read More

Russell

David Russell

We study the biology of Mycobacterium tuberculosis and HIV-1 infections in the context of our evolving appreciation of myeloid cell heterogeneity in vivo. Our studies extend to human subject analysis in Malawi and South ...
Read More

Ma

Xiaojing Ma

We investigate (1) how UBR5, a novel protein ubiquitin ligase frequently altered in human cancers, promotes tumor metastasis by regulating epithelial to mesenchymal transition (EMT) in a cell intrinsic manner;(2) to identify UBR5’s E3 ...
Read More

Mao

Yuxin Mao

Our lab studies Legionella infection and host interaction. Legionella are mainly environmental bacteria. Several species, in particular L. pneumophila and L. longbeachae, are pathogenic to humans Due to the development of artificial water systems, ...
Read More

Ivashkiv

Lionel Ivashkiv

Dr. Ivashkiv’s laboratory investigates the pathogenic mechanisms of cytokines in inflammatory and musculoskeletal conditions such as rheumatoid arthritis, osteolysis and orthopaedic implant loosening/failure, and systemic lupus erythematosus. He is interested in how cytokines and ...
Read More

Cheetham

Jonathan Cheetham

Peripheral nerve repair. Specifically, understanding the relationship between the immune response to nerve injury and recovery and modulating the immune response to improve functional outcome after injury.

Chu

C.C. Chu

New biodegradable biomaterials for a variety of biomedical applications like wound healing, drug delivery etc. Design and develop new tunable immune-responsive biomaterials to control macrophage phenotype for achieving desirable clinical outcomes.